Palomino Laboratories (PALX) Accounts Payables (2022 - 2025)

Palomino Laboratories has disclosed Accounts Payables across 4 years of filings, most recently posting $55687.0 for Q4 2025.

• Accounts Payables for Q4 2025 came in at $55687.0, up 1592.1% year-over-year; the trailing twelve-month figure through Dec 2025 was $55687.0 (up 1592.1% YoY), and the FY2025 annual result was $55687.0, up 1592.1% from the prior year.
• Accounts Payables came in at $55687.0 for Q4 2025 at Palomino Laboratories, down from $60952.0 in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $60952.0 in Q3 2025 to a low of $58.0 in Q4 2023.
• The 4-year median for Accounts Payables is $43954.0 (2024), against an average of $35037.1.
• Across the five-year window, Accounts Payables plunged 99.54% in 2023 and jumped 5574.14% in 2024, its largest moves.
• Palomino Laboratories' Accounts Payables stood at $12500.0 in 2022, then slumped by 99.54% to $58.0 in 2023, then surged by 5574.14% to $3291.0 in 2024, then surged by 1592.1% to $55687.0 in 2025.
• The last three Accounts Payables figures came in at $55687.0 (Q4 2025), $60952.0 (Q3 2025), and $40781.0 (Q2 2025), per Business Quant data.